Biocon Limited has informed the Exchange regarding a press release dated January 06, 2026, titled "Biocon Biologics to Expand Biosimilar Oncology Portfolio, Outline Strategic Vision at the 2026 J.P. Morgan Healthcare Conference.".
Biocon Limited has informed the Exchange regarding a press release dated January 06, 2026, titled "Biocon Biologics to Expand Biosimilar Oncology Portfolio, Outline Strategic Vision at the 2026 J.P. Morgan Healthcare Conference.".